GENB · NASDAQ · Biotechnology

Generate Biomedicines (GENB)

Builds protein therapeutics through a closed-loop generative-biology platform.

$16.16
Pre-market−0.11 (−0.65%)
At close$16.27(+3.04%)

Breakdown13F · 13D/G · Form 4

Institutions58 holders · as of Mar 31, 202672.41%92.82M shares
Otherremainder27.59%35.37M shares

128.19M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count has not been confirmed by a second filing; stakes use it as it stands.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Flagship Pioneering Inc.Institution
48.89%62.67M13Fas of Mar 31, 2026
FMR LLCInstitution
3.29%4.22M13Fas of Mar 31, 2026
Capital World InvestorsInstitution
3.12%4.00M13Fas of Mar 31, 2026
Braidwell LPInstitution
2.80%3.59M13Fas of Mar 31, 2026
JPMorgan Chase & CoInstitution
2.30%2.95M13Fas of Mar 31, 2026
Price T Rowe Associates Inc /MD/Institution
1.65%2.11M13Fas of Mar 31, 2026
Arch Venture Management, LLCInstitution
1.52%1.94M13Fas of Mar 31, 2026
Harbourvest Partners LLCInstitution
1.34%1.72M13Fas of Mar 31, 2026
Baker Bros. Advisors LPInstitution
1.11%1.42M13Fas of Mar 31, 2026
Harvard Management Co IncInstitution
0.87%1.11M13Fas of Mar 31, 2026
Nvidia CorpInstitution
0.65%833,32513Fas of Mar 31, 2026
Siren, L.L.C.Institution
0.57%736,10413Fas of Mar 31, 2026
Davern Capital Partners, LPInstitution
0.46%591,80013Fas of Mar 31, 2026
Alyeska Investment Group, L.P.Institution
0.39%500,00013Fas of Mar 31, 2026
Ark Investment Management LLCInstitution
0.39%498,40813Fas of Mar 31, 2026
Millennium Management LLCInstitution
0.29%376,89313Fas of Mar 31, 2026
UBS Group AGInstitution
0.28%356,70413Fas of Mar 31, 2026
Affinity Asset Advisors, LLCInstitution
0.27%350,00013Fas of Mar 31, 2026
Morgan StanleyInstitution
0.26%337,30213Fas of Mar 31, 2026
Exoduspoint Capital Management, LPInstitution
0.24%311,98613Fas of Mar 31, 2026
Centerbook Partners LPInstitution
0.21%266,81313Fas of Mar 31, 2026
Sphera Funds Management Ltd.Institution
0.14%185,00013Fas of Mar 31, 2026
Goldman Sachs Group IncInstitution
0.13%170,69513Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
0.10%131,31913Fas of Mar 31, 2026
Seven Grand Managers, LLCInstitution
0.10%125,00013Fas of Mar 31, 2026

13F — a manager's quarterly holdings

Institutions13F, as of Mar 31, 2026

58 holders · 92.82M shares · 58 new positions · 58 increased · 0 reduced · 0 closed

HolderShares% outstandingChg q/qFiled
Flagship Pioneering Inc.62.67M48.89%+62.67MnewMay 15, 2026
FMR LLC4.22M3.29%+4.22MnewMay 15, 2026
Capital World Investors4.00M3.12%+4.00MnewMay 13, 2026
Braidwell LP3.59M2.80%+3.59MnewMay 15, 2026
JPMorgan Chase & Co2.95M2.30%+2.95MnewMay 13, 2026
Price T Rowe Associates Inc /MD/2.11M1.65%+2.11MnewMay 15, 2026
Arch Venture Management, LLC1.94M1.52%+1.94MnewMay 15, 2026
Harbourvest Partners LLC1.72M1.34%+1.72MnewMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.